HCMT
STDY

Highland Capital Management (Texas)’s SteadyMed Ltd STDY Stock Holding History

Highland Capital Management (Texas)’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-109,498
Closed -$492K – 410
2018
Q2 		$492K Hold
109,498
– – 0.03% 205
2018
Q1 		$356K Sell
109,498
-15,502
-12% -$51.3K 0.02% 266
2017
Q4 		$462K Buy
+125,000
New +$404K 0.02% 219
2017
Q3 		– Sell
-251,580
Closed -$1.58M – 361
2017
Q2 		$1.58M Buy
+251,580
New +$1.71M 0.07% 153

Other funds holding STDY

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Highland Capital Management (Texas)'s STDY Position: Q3 2018 in Review

Highland Capital Management (Texas) sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 109,498 shares — an estimated $492K sold.

Highland Capital Management (Texas) first reported a position in STDY in Q2 2017 and held it in 4 quarters. The position peaked at $1.58M in Q2 2017. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

  • Highland Capital Management (Texas) reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 109,498 SteadyMed Ltd shares in Q3 2018, an estimated $492K.
  • Highland Capital Management (Texas) first reported a position in SteadyMed Ltd in Q2 2017 and held it in 4 quarters.
  • Highland Capital Management (Texas)'s SteadyMed Ltd position peaked at $1.58M in Q2 2017.
  • 5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2018, filed 14 Nov 2018.